[Development of a nanoprobe carried by E. coli that can be triggered in situ to diagnose and treat tumours]
Med Sci (Paris)
.
2025 Feb;41(2):201-202.
doi: 10.1051/medsci/2025021.
Epub 2025 Mar 3.
[Article in French]
Authors
Nolwenn Roger
1
,
Léa Moutardier
1
Affiliation
1
Master 2 Infectiologie, Immunité, Vaccinologie et Biomédicaments, Université de Tours, Tours, France.
PMID:
40028963
DOI:
10.1051/medsci/2025021
No abstract available